Bahap-Kara, M. Et Al. 2023. Interchangeability and adverse events in originator-rituximab and its biosimilar (CT-P10) among rheumatic patients: a real-life experience. Internal and Emergency Medicine , vol.18, no.3 , 791-799.

Bahap-Kara, M., Duran, E., Bayraktar-Ekincioglu, A., & KARADAĞ, Ö., (2023). Interchangeability and adverse events in originator-rituximab and its biosimilar (CT-P10) among rheumatic patients: a real-life experience. Internal and Emergency Medicine , vol.18, no.3, 791-799.

Bahap-Kara, Melda Et Al. "Interchangeability and adverse events in originator-rituximab and its biosimilar (CT-P10) among rheumatic patients: a real-life experience," Internal and Emergency Medicine , vol.18, no.3, 791-799, 2023

Bahap-Kara, Melda Et Al. "Interchangeability and adverse events in originator-rituximab and its biosimilar (CT-P10) among rheumatic patients: a real-life experience." Internal and Emergency Medicine , vol.18, no.3, pp.791-799, 2023

Bahap-Kara, M. Et Al. (2023) . "Interchangeability and adverse events in originator-rituximab and its biosimilar (CT-P10) among rheumatic patients: a real-life experience." Internal and Emergency Medicine , vol.18, no.3, pp.791-799.

@article{article, author={Melda Bahap-Kara Et Al. }, title={Interchangeability and adverse events in originator-rituximab and its biosimilar (CT-P10) among rheumatic patients: a real-life experience}, journal={Internal and Emergency Medicine}, year=2023, pages={791-799} }